ArticleBritish journal of clinical pharmacology2005

Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.

Bregt S Kappelhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.